Perez-Stable, C.; de las Pozas, A.; Wangpaichitr, M.; Foster, R.T.; Ure, D.R.
Cyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells. Biomedicines 2025, 13, 2442.
https://doi.org/10.3390/biomedicines13102442
AMA Style
Perez-Stable C, de las Pozas A, Wangpaichitr M, Foster RT, Ure DR.
Cyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells. Biomedicines. 2025; 13(10):2442.
https://doi.org/10.3390/biomedicines13102442
Chicago/Turabian Style
Perez-Stable, Carlos, Alicia de las Pozas, Medhi Wangpaichitr, Robert T. Foster, and Daren R. Ure.
2025. "Cyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells" Biomedicines 13, no. 10: 2442.
https://doi.org/10.3390/biomedicines13102442
APA Style
Perez-Stable, C., de las Pozas, A., Wangpaichitr, M., Foster, R. T., & Ure, D. R.
(2025). Cyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells. Biomedicines, 13(10), 2442.
https://doi.org/10.3390/biomedicines13102442